3 reasons to hold on to your CSL Limited shares

There’s no doubt CSL Limited is expensive, but long-term holders are still likely to reap rewards.

| More on:
a woman

Protein science and blood plasma company CSL Limited (ASX: CSL) has been pretty flat over the last six months (up less than 2%), and it yields only 1.6%, so it’s understandable that some Australian investors (who love their dividends) might be hesitant to hold. However, investors throughout the world see the value in this stock – here are three reasons why it deserves a spot in your portfolio.

1) Return on investment (ROI) has been steadily growing for 10 years. This is rare for a blue-chip superstar stock. For example, biotech company Cochlear Limited (ASX: COH) has had fairly flat ROI over the last 10 years, and mining companies tend to see their ROI fluctuate with commodity cycles.

2) Dividends have grown consistently over the last decade, with a compound annual growth rate (CAGR) of 27.3% since 2004. However the CAGR from 2010 – 2014 is just 11.2%, which I believe is more indicative for the coming decade (another decade of 27.3% dividend growth is a ludicrous suggestion, in my opinion.) However, I think 10% growth is reasonably likely, as the company continues to buy back shares.

3) The ageing population in developed nations will drive demand for CSL’s products. For example, the company’s new drug, Kcentra, is designed to treat people (undergoing surgery) who are on the drug Warfarin. Warfarin is an anti-coagulant used to reduce the risk of heart attack, and it is generally administered to people as they age. The more people who are on Warfarin, the more demand there will be for Kcentra.

Over the long term, I believe that an investment in CSL will probably beat the market. The company is considered one of the safest stocks, but I do fear it is a bit too expensive at the moment. Generally, it is better to buy shares in a company that is slightly out of favour. For example, I suggested readers buy shares in ResMed Inc. (CHESS) (ASX: RMD) after they released some disappointing results, and I would do the same if CSL temporarily disappointed the market. It’s also worth keeping in mind that were you to buy CSL at a better price, then the dividend yield would be more attractive.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor Claude Walker (@claudedwalker) does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

The share price of ASX infant products retailer Baby Bunting Group Ltd (ASX:BBN) has been a solid performer so far …

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

A new landmark report by the Intergovernmental Panel on Climate Change (IPCC) was released earlier this week. It provided a …

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest …

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos Limited (ASX: AMS) share price has been on a tear this past week, rising 15% on the back …

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

Online furniture retailer Temple & Webster Group Ltd (ASX: TPW) had a breakout year in 2020, moving from relative obscurity …

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

Shares in ASX healthcare company Polynovo Limited (ASX: PNV) almost doubled in price last year. And, despite a shaky start …

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

Investing in other geographic markets has become a popular way to diversify a portfolio. The risks associated with being exposed …

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

Despite the News Corporation (ASX: NWS) share price getting a 31% bump between November last year and today, News Corp …

Read more »